Ruokonen E, Takala J, Uusaro A
Department of Intensive Care, Kuopio University Hospital, Finland.
Crit Care Med. 1991 Nov;19(11):1365-9. doi: 10.1097/00003246-199111000-00011.
To evaluate the relationship between the mixed venous (SvO2), hepatic, and femoral venous oxygen saturations before and during sympathomimetic drug infusions.
Case series.
Tertiary care center.
Twenty-four ICU patients: postoperative open-heart surgery patients (n = 12), patients with septic shock (n = 8), and patients with acute respiratory failure (n = 4).
In postoperative open-heart surgery patients and patients with respiratory failure, cardiac output was increased by at least 25% following therapy with either dobutamine or dopamine. Patients with septic shock were treated with either dopamine or norepinephrine to correct hypotension.
Vasoactive drug infusions increased cardiac index and oxygen delivery by 34% and oxygen consumption by 8%. SvO2 increased (62.6 +/- 6.7% vs. 69.5 +/- 6.0%, p less than .001). Although cardiac index was the most important determinant of SvO2, the correlation between cardiac index and SvO2 was weak (r2 = .32). The hepatic and femoral venous saturations also increased (49.0 +/- 12.1% vs. 59.4 +/- 9.8%, p less than .01, and 51.9 +/- 16.6% vs. 63.4 +/- 9.8%, p less than .001, respectively) in response to vasoactive treatment. The mean gradient between SvO2 and hepatic venous saturation was 11.9 +/- 8.7% and was independent of the clinical condition and baseline SvO2. The hepatic venous oxygen saturation increased in parallel with SvO2 regardless of the initial SvO2 value.
The individual values of SvO2 have no predictive value concerning regional oxygen transport. The parallel increase in SvO2 and hepatic venous oxygen saturation suggests that the vasoactive treatment did not compromise splanchnic oxygenation.
评估拟交感神经药物输注前后混合静脉血氧饱和度(SvO2)、肝静脉血氧饱和度和股静脉血氧饱和度之间的关系。
病例系列研究。
三级医疗中心。
24例重症监护病房患者,包括心脏直视手术后患者(n = 12)、感染性休克患者(n = 8)和急性呼吸衰竭患者(n = 4)。
在心脏直视手术后患者和呼吸衰竭患者中,使用多巴酚丁胺或多巴胺治疗后心输出量至少增加25%。感染性休克患者使用多巴胺或去甲肾上腺素治疗以纠正低血压。
血管活性药物输注使心脏指数和氧输送量分别增加34%,氧消耗量增加8%。SvO2升高(从62.6±6.7%升至69.5±6.0%,p<0.001)。尽管心脏指数是SvO2最重要的决定因素,但心脏指数与SvO2之间的相关性较弱(r2 = 0.32)。血管活性治疗后,肝静脉血氧饱和度和股静脉血氧饱和度也升高(分别从49.0±12.1%升至59.4±9.8%,p<0.01;从51.9±16.6%升至63.4±9.8%,p<0.001)。SvO2与肝静脉血氧饱和度之间的平均差值为11.9±8.7%,且与临床状况和基线SvO2无关。无论初始SvO2值如何,肝静脉血氧饱和度均与SvO2平行升高。
SvO2的个体值对区域氧输送无预测价值。SvO2与肝静脉血氧饱和度的平行升高表明血管活性治疗未损害内脏氧合。